These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 23716070)

  • 1. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.
    Giles JT; Danoff SK; Sokolove J; Wagner CA; Winchester R; Pappas DA; Siegelman S; Connors G; Robinson WH; Bathon JM
    Ann Rheum Dis; 2014 Aug; 73(8):1487-94. PubMed ID: 23716070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases.
    Chen RX; Zhao LD; Xiao XY; Song L; Du HY; Xu ZJ; Feng RE; Yang HX; Fei YY; Zhang W; Zhang FC; Chen H; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):46-54. PubMed ID: 33170478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease.
    Castellanos-Moreira R; Rodríguez-García SC; Gomara MJ; Ruiz-Esquide V; Cuervo A; Casafont-Solé I; Ramírez J; Holgado S; Gómez-Puerta JA; Cañete JD; Haro I; Sanmarti R
    Ann Rheum Dis; 2020 May; 79(5):587-594. PubMed ID: 32156708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis.
    Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Sköld M; Grunewald J; Chatzidionysiou K; Catrina A
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease in Women with Rheumatoid Arthritis.
    Rocha-Muñoz AD; Ponce-Guarneros M; Gamez-Nava JI; Olivas-Flores EM; Mejía M; Juárez-Contreras P; Martínez-García EA; Corona-Sánchez EG; Rodríguez-Hernández TM; Vázquez-del Mercado M; Salazar-Páramo M; Nava-Zavala AH; Cardona-Muñoz EG; Celis A; González-Lopez L
    J Immunol Res; 2015; 2015():151626. PubMed ID: 26090479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial lung disease throughout the rheumatoid arthritis disease course.
    McDermott GC; Doyle TJ; Sparks JA
    Curr Opin Rheumatol; 2021 May; 33(3):284-291. PubMed ID: 33625044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies.
    Cornillet M; Sebbag M; Verrouil E; Magyar A; Babos F; Ruyssen-Witrand A; Hudecz F; Cantagrel A; Serre G; Nogueira L
    Ann Rheum Dis; 2014 Jun; 73(6):1246-52. PubMed ID: 23636655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease.
    Del Angel-Pablo AD; Buendía-Roldán I; Mejía M; Pérez-Rubio G; Nava-Quiroz KJ; Rojas-Serrano J; Falfán-Valencia R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32168865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
    Yin Y; Liang D; Zhao L; Li Y; Liu W; Ren Y; Li Y; Zeng X; Zhang F; Tang F; Shan G; Zhang X
    PLoS One; 2014; 9(4):e92449. PubMed ID: 24743261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis.
    Inui N; Enomoto N; Suda T; Kageyama Y; Watanabe H; Chida K
    Clin Biochem; 2008 Sep; 41(13):1074-7. PubMed ID: 18638466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
    Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
    Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
    BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
    Doyle TJ; Patel AS; Hatabu H; Nishino M; Wu G; Osorio JC; Golzarri MF; Traslosheros A; Chu SG; Frits ML; Iannaccone CK; Koontz D; Fuhrman C; Weinblatt ME; El-Chemaly SY; Washko GR; Hunninghake GM; Choi AM; Dellaripa PF; Oddis CV; Shadick NA; Ascherman DP; Rosas IO
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1403-12. PubMed ID: 25822095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity.
    Zhu J; Zhou Y; Chen X; Li J
    J Rheumatol; 2014 Jul; 41(7):1282-9. PubMed ID: 24882837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
    Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease.
    Ota M; Iwasaki Y; Harada H; Sasaki O; Nagafuchi Y; Nakachi S; Sumitomo S; Shoda H; Tohma S; Fujio K; Yamamoto K
    Mod Rheumatol; 2017 Jan; 27(1):22-28. PubMed ID: 27142966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.